Pfizer Says It Needs to Study a Third Dose for Toddlers

by Dr. Joseph Mercola, public domain

(Jan. 4, 2022) — Children are the future. Over the centuries, many have suffered atrocities at the hands of adults. Yet the recent push to inject children with a genetic experiment may be one of the worst public health offenses perpetrated on a population of people who are unable to speak for themselves, do not have a legal voice and depend on adults to protect them.

In the push to ensure there is a shot in every arm, Pfizer recently announced the clinical trials for the COVID jab in children has hit a snag.¹ And yet, you would be hard-pressed to call the “Warp Speed” creation, testing and manufacture of this shot anything but implausible.

Historically, Vaccines Have Been Pulled After Reported Damage

At no other time in history have “vaccines” been created and distributed with such impunity. The closest scenario occurred in 1976 when one young soldier died from a new form of flu that triggered fear and the subsequent development of a flu vaccine aimed at 80% of the American public.² While the World Health Organization took a “wait and see” approach, the CDC jumped in with both feet.

It was a pandemic that never materialized and those who were the real victims were the roughly 450 people who developed Guillain-Barre syndrome,³ a rare neurological disorder, and the roughly 53 who died from the vaccine.⁴

The rush to produce the newest vaccine iteration ostensibly began in early 2020 after the WHO announced SARS-CoV-2 would produce a worldwide pandemic⁵ and an early, flawed mathematical model predicted millions of deaths in America.⁶ Yet, this was not a medical product that fit the definition of a “vaccine.”

It was something never heard of before in vaccinology, based on an experimental mRNA technology that triggers your body to produce a spike protein. It was so new, in fact, that the CDC decided the definition of “vaccine” had to be changed⁷ and scientists were unsure of how the body would react to the genetic therapy injection. While the swine flu injection was pulled after 45 million shots were given when 53 people died,⁸ the COVID-19 injection will have a different history.

According to data from the Vaccine Adverse Events Reporting System (VAERS), collected by the CDC and FDA, there have been 20,244 deaths recorded in conjunction with the COVID jabs as of December 10, 2021,⁹ 12 months after the first shot was given in the U.S.¹⁰ According to Bloomberg, as of December 23, 2021, there have been 499 million doses given in America.¹¹

It is difficult to compare these numbers since two of the three available COVID shots require a double shot, so there haven’t been 497 million people vaccinated. Yet, the adverse events and deaths are also occurring after just one shot.

Taken at face value, the U.S. shut down the vaccination program in 1976 after 0.000117% of people died, while the VAERS estimate is that 0.00407% of people have died after a COVID injection (using Bloomberg’s December 21 dose numbers of 497 million).

In other words, based on the percentage of people who have died, 3,378% more died after the COVID injection than from the swine flu injection. There have been 965,841 adverse events reported, including permanent disabilities and heart attacks in young people. And yet, stakeholders in the shot insist the next generation of Americans must take it.

Pfizer Announced Youngest Kids Not Responding to the Shot

Pfizer has been working on a clinical trial¹² to evaluate the safety of the mRNA jab in healthy children, intending to create a dose for children 6 months and older. Endpoints reports Pfizer recently announced “non-inferiority was not met for children between the ages of 2 and 5 when compared to older teenagers in the current trial.”¹³

Originally, the company hoped to apply for an emergency use authorization (EUA) for the youngest by the end of December 2021. However, since the data have not proven successful, they hope to submit for the EUA “in the first half of 2022,”¹⁴ one short year after starting the experiment. The company said it has made a shift to giving three doses in smaller amounts to raise the immune response.¹⁵ They explain the decision this way:

“Compared to the 16- to 25-year-old population in which high efficacy was demonstrated, non-inferiority was met for the 6- to 24-month-old population but not for the 2- to under 5-year-old population in this analysis …

The decision to evaluate a third dose of 3 µg for children 6 months to under 5 years of age reflects the companies’ commitment to carefully select the right dose to maximize the risk-benefit profile …

Pfizer and BioNTech also plan to evaluate a third dose of the 10 µg formulation in children 5 to under 12 years of age.”

If the two-dose regimen makes the changes to the immune system in the 6- to 24-months group and 5- to 12-year age groups that the company is looking for, why move to a three-dose regimen for them if not for financial gain?

Pfizer Pushing the Envelope With a Phase 1-2-3 Trial

It is important to note that the trial is listed in Clinical Trials as a phase 1-2-3 study.¹⁶ Phase 1 trials¹⁷ are generally concerned with establishing drug safety and dose range in a small number of healthy volunteers. Phase 2 trials determine the effectiveness of the drug using approximately 100 to 300 volunteers and often last from several months to two years.

Phase 3 studies are the final evaluation performed over multiple centers with up to several thousand patients to test the drug safety and efficacy. A search of the Clinical Trials database shows only one study in several hundred thousand studies listed that are simultaneously in Phase 1, 2 and 3.¹⁸

But not all parents and scientists are appalled by the experimentation on 6-month-old babies in the face of massive adverse events and permanent damage to adults. One mother and epidemiologist, Katelyn Jetelina,¹⁹ wrote she finds comfort that the clinical trial found errors and was surprised when it failed. She wrote:²⁰

“As a mom, I was shocked and heartbroken. My girls were so close to getting their shot. We’ve waited so long and really needed a win.”

Children Are Not at Risk From COVID

Despite low rates of infection and death, the American Academy of Pediatrics calls “vaccines our best hope to end the COVID-19 pandemic.”²¹ However, we do know that the risk to children birth to 17 years is so small as to be inconsequential.

The CDC²² reports a total number of deaths in 2020 and 2021 from COVID-19 in this age group as 668 as of December 23, 2021. One study²³ posted July 7, 2021, looked at deaths in the U.K. during the first 12 months of the pandemic and found that 99.995% of children survived.

Between March 2020 and February 2021 only 25 children under the age of 18 had died in the U.K. as a direct result of the infection. The researchers found there were 61 children with positive test results, but 36 deaths were attributed to other causes. This is a 2-in-1 million absolute mortality rate for children.²⁴

Read the rest here for a limited time or download the article:

Also see Dr. Mercola’s announcement of a new “Censored Library” soon to become available to subscribers.